President Donald Trump is doubling down on support for medical marijuana—calling it “the best of all the alternatives” for people dealing with serious illnesses.
The comments came as his administration moves forward with a major shift in federal cannabis policy, pushing to reclassify marijuana from a Schedule I drug to Schedule III. That change recognizes its medical value and opens the door for more research and wider patient access.
Trump pointed to real-world experiences, highlighting stories of people who struggled with traditional medications but found better relief with cannabis. According to him, patients dealing with “big problems” are seeing meaningful improvements—and they’re “very happy about it.”
The rescheduling effort itself is a big deal. For decades, marijuana has been grouped alongside drugs like heroin, with “no accepted medical use.” Moving it to Schedule III signals a shift in how the federal government views cannabis—not as a fringe treatment, but as something worth studying, prescribing, and potentially integrating into mainstream care.
Still, this isn’t full legalization. Recreational use remains illegal at the federal level, and the policy change is focused strictly on medical access and research.
The conversation around cannabis is changing fast—and now it’s coming straight from the top.
Dabbin-Dad Newsroom
